Resource
Library

Find publications that are relevant to our scientific approach, including those related to our product candidates.

  • Programs & Targets

  • Year

  • Resource Type/Format

  • Development Stage

  • Conference/Event

Related Resources
December 7, 2025
CD62L Enrichment Achieves Robust Expansion and Memory Phenotype Post-Infusion in Patients with LBCL Treated with Rondecabtagene Autoleucel, an Autologous, Dual-Targeting CD19/CD20 CAR T-Cell Candidate
ASH
DOI: 10.1182/blood-2025-501
Akil Merchant, Ben Harris, Lora Zhao, Sahithi Cheemalamarri, Shobha Potluri, Tahir Latif, Umar Farooq, Sarah M. Larson
Presentation
Read More
December 7, 2025
Rondecabtagene Autoleucel, an Autologous, Dual-Targeting CD19/CD20 CAR T-Cell Candidate Manufactured from CD62L+ Enriched T Cells, Achieves Durable Responses in Patients with Large B-Cell Lymphoma
ASH
Sarah M. Larson, Umar Farooq, Tahir Latif, Felix Mensah, Bradley D. Hunter, Stefan O. Ciurea, Nebu Koshy, Locke Bryan, Boyu Hu, William Clark, Hassaan Yasin, Yeonhee Kim, Greg Kaufman, Akil Merchant
Presentation
Read More
September 1, 2025
Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial
JAMA Oncology
Naifei Chen, MD, PhD, Chengfei Pu, BS, Lingling Zhao, MD, PhD, et al
Journal
Read More
June 18, 2025
LYL314, a CD19/CD20 CAR T-Cell Candidate Enriched for CD62L+Stem-Like Cells, Achieves High Rates of Durable Complete Responses in R/R Large B-Cell Lymphoma
ICML
DOI:10.1002/hon.70093_106
Akil Merchant, Umar Farooq, Tahir Latif, Felix Mensah, Bradley D. Hunter, Locke Bryan, Stefan O. Ciurea, Boyu Hu, William Clark, Hassaan Yasin, Yeonhee Kim, Ben Harris, Greg Kaufman, Sarah M. Larson
Presentation
Read More